OKYO Pharma Announces PDMR Dealing | MarketScreener

LONDON and NEW YORK, March 24, 2023 -- OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant... | March 24, 2023

Related Keywords

United Kingdom ,London ,City Of ,Robert Emmet ,Gabriele Cerrone ,Paul Spencer ,Garys Jacob ,Panetta Partners ,Optiva Securities ,London Stock Exchange ,Pharma Limited ,Pharma Limited Nasdaq ,Nasdaq ,Company Adss ,Panetta Partners Limited ,Executive Chairman ,Chief Executive ,Official List ,United Kingdom Financial Conduct Authority ,Okyo Pharma Limited Stock Exchange ,News ,Information ,Press Release ,End ,Few ,Arch ,023 ,Tokyo ,Dharma ,Imited ,N ,Company ,Which ,Us ,Developing ,O ,Treat ,Mary ,Eye ,Disease ,Address ,He Okyo Gg00bd3fv870 ,